Trupanion (NASDAQ: TRUP) stock soared 43.8% last month, according to data from S&P Global Market Intelligence. For context, the S&P 500 returned 3.6% in November.
Shares of the provider of medical insurance plans for cats and dogs have gained 31.1% in 2019, as of Dec. 2. That's slightly better than the broader market's 26.5% return over this period.
Image source: Getty Images.
We can attribute Trupanion stock's powerful performance last month largely to the company's Nov. 5 release of third-quarter results that delighted investors. Shares popped 23.2% the next day and continued their upward climb throughout the month.
In Q3, Trupanion's total revenue jumped 27% year over year to $99.3 million. Growth was driven by a 23% increase in the number of total enrolled pets to 613,694. Subscription revenue rose 23% to $82.6 million, driven by a 15% rise in the number of subscription enrolled pets to 479,427. Net income was $0.8 million, or $0.02 per share, down slightly from $1.2 million, or $0.03 per share, in the year-ago period. Nonetheless, that result was good enough to easily beat the $0.02 per-share loss that Wall Street was expecting.
Trupanion, which went public in 2014, is worth putting on your watch list. Its total addressable market in the Unites States and Canada is huge -- about 200 million pets, according to its November 2019 investor presentation -- and very underpenetrated relative to other developed markets. About 1% of U.S. pets and 2% of Canadian pets are covered by pet insurance, compared with about 25% in the U.K., according to this presentation.
10 stocks we like better than Trupanion
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Trupanion wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of June 1, 2019
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.